Search

Search Results

Found 94 items.

Effect on prostatic specific antigen by a short time treatment with a Curcuma extract: A real life experience and implications for prostate biopsy

Andrea Fabiani, Carolina Morosetti, Alessandra Filosa, Emanuele Principi, Luca Lepri, Valentina Maurelli, Fabrizio Fioretti, Lucilla Servi

107-111

2018-06-30

Published: June 30, 2018

2293

PDF: 798
Empiric antibiotics therapy for mildly elevated prostate specific antigen: Helpful to avoid unnecessary biopsies?

Andrea Fandella, Sara Benvenuto, Elisa Guidoni, Marco Giampaoli, Alessandro Bertaccini

202-204

2014-09-30

Published: September 30, 2014

1754

PDF: 1129
The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy

Antonio B. Porcaro, Beatrice Caruso, Alessandro Terrin, Nicolò De Luyk, Giovanni Cacciamani, Paolo Corsi, Davide Inverardi, Davide De Marchi, Roberto Baldassarre, Mariangela Cerruto, Claudio Ghimenton, Matteo Brunelli, Stefano Zecchini Antoniolli, Aldo Petrozziello, Walter Artibani

17-22

2016-03-31

Published: March 31, 2016

2017

PDF: 841

SUPPLEMENTARY MATERIAL: 322
Does prolonged anti-inflammatory therapy reduce number of unnecessary repeat saturation prostate biopsy?

Giuseppe Candiano, Pietro Pepe, Francesco Pietropaolo, Francesco Aragona

65-68

2013-06-24

Published: June 24, 2013

1767

PDF: 1691
Evaluation of the pathologic results of prostate biopsies in terms of age, Gleason score and PSA level: Our experience and review of the literature

Selcuk Sarıkaya, Mustafa Resorlu, Ural Oguz, Mustafa Yordam, Omer Faruk Bozkurt, Ali Unsal

288-290

2014-12-30

Published: December 30, 2014

2683

PDF: 1398
The sufficiency of 6 core sextant prostate biopsy in patients with prostate specific antigen (PSA) values over 20 ng/mL

Cem Yücel, Salih Budak, Erdem Kısa, Orcun Celik, Zafer Kozacıoglu

104-106

2018-06-30

Published: June 30, 2018

1442

PDF: 513
A retrospective comparison between transrectal and transperineal prostate biopsy in the detection of prostate cancer

Carmelo Agostino Di Franco, Hussein Jallous, Daniele Porru, Giovanni Luca Giliberto, Tiziano Cebrelli, Carmine Tinelli, Bruno Rovereto

55-59

2017-03-31

Published: March 31, 2017

2821

PDF: 1671
Medical management in locally advanced and metastatic prostate cancer: Does changes in treatment policy have any specific effect on PSA levels?

Murat Bagcioglu, Cristian Surcel, Serkan Ozcan, Cristian Mirvald, Mehmet Ali Karagoz, Mert Ali Karadag, Emre Huri, Kemal Sarica

282-286

2017-12-31

Published: December 31, 2017

1083

PDF: 571
The factors predicting biochemical recurrence in patients with radical prostatectomy

Osman Koca, Sıtkı Ün, Hakan Türk, Ferruh Zorlu

270-275

2016-01-14

Published: January 14, 2016

2299

PDF: 800
Accuracy of pelvic multiparametric MRI in diagnosing local recurrence following radical prostatectomy. Case report and revision of the literature

Pietro Pepe, Antonio Garufi, Giandomenico Priolo, Michele Pennisi

335-336

2016-01-14

Published: January 14, 2016

1856

PDF: 764
In the search of novel urine biomarkers for the early diagnosis of prostate cancer. Intracellular or secreted proteins as the target group? Where and how to search for possible biomarkers useful in the everyday clinical practice

Amalia Katafigioti, Ioannis Katafigiotis, Stavros Sfoungaristos, Christos Alamanis, Konstantinos Stravodimos, Ioannis Anastasiou, Eleni Roumelioti, Mordechai Duvdevani, Constantinos Constantinides

195-200

2016-10-05

Published: October 5, 2016

2659

PDF: 1300
Lymphocyte-to-monocyte ratio is a valuable marker to predict prostate cancer in patients with prostate specific antigen between 4 and 10 ng/dl

Volkan Caglayan, Efe Onen, Sinan Avci, Murat Sambel, Metin Kilic, Sedat Oner, Mustafa Murat Aydos, Halil Emre Yıldız

270-275

2019-01-17

Published: January 17, 2019

2344

PDF: 1372
The correlation between biological activity and diffusion-weighted MR imaging and ADC value in cases with prostate cancer

Bedriye Koyuncu Sokmen, Dogukan Sokmen, Nese Ucar, Huseyin Ozkurt, Abdulmuttalip Simsek

277-281

2017-12-31

Published: December 31, 2017

1305

PDF: 566
Evaluation of various active surveillance protocols in prostate cancer

Kayhan Yılmaz, Tahir Karadeniz, Orkunt Özkaptan, Oguz Yilanoglu

81-85

2014-06-30

Published: June 30, 2014

1764

PDF: 777
Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy

Pietro Pepe, Antonio Garufi, Giandomenico Priolo, Giuseppe Dibenedetto, Michele Salemi, Michele Pennisi, Filippo Fraggetta, Francesco Aragona, Michele Barbera

336-339

2014-12-30

Published: December 30, 2014

2295

PDF: 1540
Comparative randomized study on the efficaciousness of endoscopic bipolar prostate resection versus monopolar resection technique. 3 year follow-up

Roberto Giulianelli, Luca Albanesi, Francesco Attisani, Barbara Cristina Gentile, Giorgio Vincenti, Francesco Pisanti, Teuta Shestani, Luca Mavilla, David Granata, Manlio Schettini

86-91

2013-06-24

Published: June 24, 2013

5203

PDF: 3207
Widespread high grade prostatic intraepithelial neoplasia on biopsy predicts the risk of prostate cancer: A 12 months analysis after three consecutive prostate biopsies

Cosimo De Nunzio, Simone Albisinni, Antonio Cicione, Mauro Gacci, Costantino Leonardo, Francesco Esperto, Andrea Tubaro

59-64

2013-06-24

Published: June 24, 2013

1939

PDF: 1514
Effect of green tea catechins in patients with high-grade prostatic intraepithelial neoplasia: Results of a short-term double-blind placebo controlled phase II clinical trial

Salvatore Micali, Angelo Territo, Giacomo Maria Pirola, Nancy Ferrari, Maria Chiara Sighinolfi, Eugenio Martorana, Michele Navarra, Giampaolo Bianchi

197-202

2017-10-03

Published: October 3, 2017

2654

PDF: 1416
Effect of microorganisms on etiology of hematospermia

Musa Saracoglu, Hakan Ozturk, Arzu Duran, Sabri Atalay

80-82

2015-03-31

Published: March 31, 2015

2250

PDF: 1192
Association between large prostate calculi and prostate cancer

Cem Yucel, Salih Budak

181-183

2018-09-30

Published: September 30, 2018

1312

PDF: 548
The eternal enigma in prostatic biopsy access route

Andrea Fabiani, Emanuele Principi, Alessandra Filosa, Lucilla Servi

245-246

2017-10-03

Published: October 3, 2017

1998

PDF: 1135
Is there a PSA cut-off value indicating incidental prostate cancer in patients undergoing surgery for benign prostatic hyperplasia?

Senol Tonyali, Cavit Ceylan, Erdogan Aglamis, Serkan Dogan, Sedat Tastemur, Mustafa Karaaslan

31-34

2021-03-18

Published: March 18, 2021

1237

PDF: 628
Evaluation of Tl-201 SPECT imaging findings in prostate cancer

Sinem Ozyurt, Gokhan Koca, Akif Diri, Koray Demirel, Tolga Karakan, Berkan Resorlu, Meliha Korkmaz, Cankon Germiyanoglu

147-150

2015-07-07

Published: July 7, 2015

1756

PDF: 706

SUPPLEMENTARY MATERIAL: 560
Correlation between lower urinary tract symptoms and objective measures of uroflowmetry

Hakan Türk, Sıtkı Ün

130-133

2017-06-30

Published: June 30, 2017

1450

PDF: 1003
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection

Eugenio Brunocilla, Riccardo Schiavina, Cristina Nanni, Marco Borghesi, Matteo Cevenini, Enrico Molinaroli, Valerio Vagnoni, Paolo Castellucci, Francesco Ceci, Stefano Fanti, Caterina Gaudiano, Rita Golfieri, Giuseppe Martorana

239-240

2014-09-30

Published: September 30, 2014

2121

PDF: 930

SUPPLEMENTARY MATERIAL: 364
Diagnostic efficacy and safety of transperineal prostate targeted and systematic biopsy: The preliminary experience of first 100 cases

Shahbaz Mehmood, Khalid Ibraheem Alothman, Abdulaziz Alwehaibi, Samia Mohamed Alhashim

127-131

2021-06-28

Published: June 28, 2021

1128

PDF: 503
Prostate-speciﬁc antigen response after Abiraterone treatment in mCRPC: PSA as a predictor of overall survival

Alexandre Mendonça Macedo, Rita Gameiro Marques, Margarida Cunha André, Nuno Silva Figueira, Miguel Leal Carvalho

2023-02-22

Published: February 22, 2023

1006

PDF: 596
Lidocaine spray administration in transrectal ultrasound-guided prostate biopsy: Five years of experience

Lucio Dell’Atti

340-343

2014-12-30

Published: December 30, 2014

1486

PDF: 760
Clinical significance of prostatic-urethral angulation on the treatment outcome of patients with symptomatic benign prostatic hyperplasia treated with tamsulosin hydrochloride

Hassan El-Tatawy, Tarek Gameel, Mohammed Abo El-enen, Ayman Hagras, Ayman Mousa, Abdel Hamid El-Bahnasy, Ali Abdel Raheem, Khaled Abu-dewan

238-242

2015-09-30

Published: September 30, 2015

1761

PDF: 915
Potential usefulness of CTC detection in follow up of prostate cancer patients. A preliminary report obtained by using Adnagene platform

Giuseppe Albino, Francesca Vendittelli, Carmela Paolillo, Cecilia Zuppi, Ettore Capoluongo

164-169

2013-12-31

Published: December 31, 2013

2142

PDF: 2022
Pulmonary recurrence from prostate cancer and biochemical remission after metastasis directed therapy. A case report

Riccardo Boschian, Michele Rizzo, Lorenzo Zandonà, Carlo Trombetta, Giovanni Liguori

74-75

2018-03-31

Published: March 31, 2018

1284

PDF: 560
Primary adenocarcinoma of the seminal vesicles. A review of the literature

Ioannis Katafigiotis, Stavros Sfoungaristos, Mordechai Duvdevani, Panagiotis Mitsos, Eleni Roumelioti, Konstantinos Stravodimos, Ioannis Anastasiou, Constantinos A. Constantinides

47-51

2016-03-31

Published: March 31, 2016

3604

PDF: 2677
Prospective observational study on the efficacy and tolerability of a complex of phytochemicals vs. dutasteride in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia

Giuseppe Saitta, Franco A. Mantovani, Benedetto Calabrese, Camilla Aliboni, Giuseppe Di Paola, Attilio L. Meazza, Mauro Seveso

2024-10-02

Published: October 2, 2024

543

PDF: 226
Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy

Pietro Pepe, Sebastiano Cimino, Antonio Garufi, Giandomenico Priolo, Giorgio Ivan Russo, Raimondo Giardina, Giulio Reale, Michele Barbera, Paolo Panella, Michele Pennisi, Giuseppe Morgia

300-303

2016-12-30

Published: December 30, 2016

2325

PDF: 1225
MRI/US fusion prostate biopsy: Our initial experience

Vito Lacetera, Bernardo Cervelli, Antonio Cicetti, Giuliana Gabrielloni, Michele Montesi, Roberto Morcellini, Gianni Parri, Emilio Recanatini, Gianluca Giglioni, Andrea Benedetto Galosi, Valerio Beatrici

296-299

2016-12-30

Published: December 30, 2016

2846

PDF: 1311
Factors affecting surgical margin positivity in robotic assisted radical prostatectomy

Mustafa Yuksel, Kaan Karamık, Hakan Anıl, Ekrem Islamoglu, Mutlu Ates, Murat Savas

71-74

2017-03-31

Published: March 31, 2017

1603

PDF: 894
Negative biopsy histology in men with PI-RADS score 5: is it useful PSMA PET/CT evaluation?

Pietro Pepe, Ludovica Pepe, Michele Pennisi

2024-06-27

Published: June 27, 2024

1295

PDF: 294
The effectivity of periprostatic nerve blockade for the pain control during transrectal ultrasound guided prostate biopsy

Alper Otunctemur, Murat Dursun, Huseyin Besiroglu, Emre Can Polat, Suleyman Sami Cakir, Emin Ozbek, Tahir Karadeniz

69-72

2013-06-24

Published: June 24, 2013

1949

PDF: 1918
Outcomes of active surveillance for clinically localized prostate cancer in a middle eastern tertiary care center

Mohammad Hout, Ali Merhe, Nassib Abou Heidar, Jose M. El-Asmar, Wassim Wazzan, Bassel Bachir, Rola Jaafar, Albert El-Hajj, Muhammad Bulbul

385-388

2021-12-20

Published: December 20, 2021

1139

PDF: 397
Can perineural invasion detected in prostate needle biopsy specimens predict surgical margin positivity in D’Amico low risk patients?

Ozgur Haki Yuksel, Ahmet Urkmez, Ayhan Verit

89-92

2016-07-04

Published: July 4, 2016

1608

PDF: 770
Daidzein plus isolase associated with zinc improves clinical symptoms and quality of life in patients with LUTS due to benign prostatic hyperplasia: Results from a phase I-II study

Daniele Tiscione, Luca Gallelli, Irene Tamanini, Lorenzo Giuseppe Luciani, Paolo Verze, Alessandro Palmieri, Vincenzo Mirone, Riccardo Bartoletti, Gianni Malossini, Tommaso Cai

12-16

2017-03-31

Published: March 31, 2017

2321

PDF: 1035
Single plus one port robotic radical prostatectomy (SPORP); Initial experience

Volkan Tugcu, Abdulmuttalip Simsek, Ismail Evren, Kamil Gokhan Seker, Ramazan Kocakaya, Bugra Dogukan Torer, Arda Atar, Ali Ihsan Tasci

178-181

2017-10-03

Published: October 3, 2017

1429

PDF: 894
Erectile function after repeat saturation prostate biopsy: Our experience in 100 patients

Pietro Pepe, Francesco Pietropaolo, Giuseppe Dibenedetto, Francesco Aragona

130-132

2013-09-26

Published: September 26, 2013

1798

PDF: 1546
Do all patients with suspicious prostate cancer need Multiparametric Magnetic Resonance Imaging before prostate biopsy?

Sara Teixeira Anacleto, Joana Neves Alberto, Emanuel Carvalho Dias, Pedro Sousa Passos, Mário Cerqueira Alves

32-36

2022-03-28

Published: March 28, 2022

636

PDF: 391
Robotic perineal radical prostatectomy with high prostate volume

Volkan Tugcu, Abdulmuttalip Simsek, Ismail Yigitbasi, Mustafa Gürkan Yenice, Selcuk Sahin, Ali Ishsan Tasci

65-67

2018-03-31

Published: March 31, 2018

1279

PDF: 683
Transrectal versus transperineal 14-core prostate biopsy in detection of prostate cancer: A comparative evaluation at the same Institution

Maria Angela Cerruto, Fabio Vianello, Carolina D’Elia, Walter Artibani, Giovanni Novella

284-287

2014-12-30

Published: December 30, 2014

3897

PDF: 1580
Erectile dysfunction in patients taking psychotropic drugs and treated with phosphodiesterase-5 inhibitors

Rossella Mazzilli, Gloria Angeletti, Soraya Olana, Michele Delfino, Virginia Zamponi, Chiara Rapinesi, Antonio Del Casale, Georgios D. Kotzalidis, Jlenia Elia, Gemma Callovini, Paolo Girardi, Fernando Mazzilli

44-48

2018-03-31

Published: March 31, 2018

2189

PDF: 1375
Prognostic value of subclassification (pT2 stage) of pathologically organ-confined prostate cancer: Confirmation of the changes introduced in the 8th edition of the American Joint Committee on Cancer (AJCC) staging system

Hugo Pontes Antunes, Belmiro Parada, João Carvalho, Miguel Eliseu, Roberto Jarimba, Rui Oliveira, Edgar Tavares-da-Silva, Arnaldo Figueiredo

191-194

2018-09-30

Published: September 30, 2018

998

PDF: 575
Resident training in urology: Bipolar transurethral resection of the prostate - a safe method in learning endoscopic surgical procedure

Alessandro Del Rosso, Stefano Masciovecchio, Giuseppe Paradiso Galatioto, Carlo Vicentini

78-81

2013-06-24

Published: June 24, 2013

1807

PDF: 1638
Role of sterile pyuria in association to elevated PSA values in the diagnosis of non-palpable prostate cancer?

Selamettin Demir

2019-10-02

Published: October 2, 2019

1481

PDF: 675

1 - 50 of 94 items 1 2 > >>

© PAGEPress 2008-2024 • PAGEPress^® is a registered trademark property of PAGEPress srl, Italy • VAT: IT02125780185 • Privacy